511
Participants
Start Date
April 24, 2013
Primary Completion Date
December 16, 2016
Study Completion Date
December 16, 2016
Nilvadipine
8mg of Nilvadipine taken once a day at lunch time for 78 weeks
Placebo
8mg Placebo tablet taken once a day at lunch time for 78 weeks
Centre Hospitalier Universitaire d'Amiens (CHU Amiens), Amiens
Centre Hospitalier Universitaire de Bethune (CH Bethune), Béthune
Centre Hospitalier Universitaire de Caen (CHU Caen), Caen
Centre Hospitalier Universitaire de Calais (CHU Calais), Calais
Centre Hospitalier Universitaire de Lens (CHU Lens), Lens
Centre Hospitalier Regional et Universitaire de Lille (CHRU Lille), Lille
Centre Hospitalier Universitaire de Saint Philibert (GHICL), Lille
University of Ulm, Ulm
"G. Papanicolaou Hospital", Athens
"G.Papageorgiou Hospital", Athens
AXEPA Hospital, Athens
Szeged University, Szeged
University College Cork, Cork
St James Hospital, Dublin
Hospital of Brescia, Brescia
Hospital Castellanza, Castellanza
Hospital of Genoa, Genoa
Hospital of Milan, Milan
Hospital of Arnhem, Arnhem
Hospital of Maastricht, Maastricht
Hospital of Nijmegen, Nijmegen
Gothenburg Univeristy, Gothenburg
Kings College London, London
Collaborators (2)
University of Dublin, Trinity College
OTHER
Molecular Medicine Ireland LBG
UNKNOWN
Alzheimer Europe
OTHER
Archer Pharmaceuticals, Inc.
INDUSTRY
E-Search Limited
UNKNOWN
University College Dublin
OTHER
King's College London
OTHER
Istituto Di Ricerche Farmacologiche Mario Negri
OTHER
University Hospital, Lille
OTHER
University of Ulm
OTHER
Szeged University
OTHER
Göteborg University
OTHER
University College Cork
OTHER
Aristotle University Of Thessaloniki
OTHER
Stichting Katholieke Universiteit
OTHER
Prof Brian Lawlor
OTHER